9 results match your criteria: "Boao Super Hospital[Affiliation]"
Zhonghua Yu Fang Yi Xue Za Zhi
December 2024
Department of Otorhinolaryngology & Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing210029, China International Centre for Allergy Research, Nanjing Medical University, Nanjing210029, China.
To investigate the short-term effectiveness and safety of sublingual allergen immunotherapy with allergen sprays (SLIT-sprays) in Chinese patients with allergic rhinitis (AR) with or without asthma using real-world data. The retrospective cohort study included 100 patients who received SLIT-sprays in the ENT departments in Hainan Shulan (Boao) Hospital and Boao Super Hospital between October 2023 and August 2024. A questionnaire survey was conducted to collect clinical data on the effectiveness and safety of SLIT-sprays, examining the types and incidence of adverse events (AEs) during treatment, treatments after the occurrence of AEs, and changes in Visual Analog Scale (VAS) scores before and after SLIT-sprays.
View Article and Find Full Text PDFBr J Dermatol
November 2024
Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
PLoS One
September 2024
Department of Otolaryngology and Head and Neck Surgery, Boao Super Hospital, Qionghai, China.
Front Oncol
July 2024
Department of Oncology II, Hainan Cancer Hospital, Haikou, Hainan, China.
MET exon 14 (METex14) skipping is the most reported MET mutation in non-small cell lung cancer (NSCLC) and has been confirmed to respond to MET tyrosine kinase inhibitors (TKI) in clinical trials. While MET TKI tepotinib was recently approved for METex14 skipping NSCLC in China, real-world evidence is limited. We report our experience treating NSCLC patients referred from oncology sites across China with tepotinib in the Boao Lecheng Pilot Zone.
View Article and Find Full Text PDFEur J Dermatol
February 2024
Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China, Department of Dermatology, Dushu Lake Hospital Affiliated to Soochow University (Medical Center of Soochow University, Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Data on guselkumab as treatment for moderate-to-severe plaque psoriasis, especially in different body regions, in China is limited. This study aimed to estimate the effectiveness of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis, including effectiveness at different body regions. This multicentre, observational study retrospectively enrolled patients with moderate-to-severe plaque psoriasis.
View Article and Find Full Text PDFAm J Ophthalmol
August 2023
From the National Clinical Research Center for Ocular Diseases (M.L., H.W., L.L., C.G., L.G., Q.Z., W.C.), Eye Hospital, Wenzhou Medical University, Wenzhou, China; Department of Ophthalmology (M.L., L.G., W.C.), Boao Super Hospital, Hainan, China. Electronic address:
Purpose: To report the short-term visual outcomes and complications of a modified Boston Type-II keratoprosthesis (Kpro) procedure.
Design: Retrospective case series.
Methods: Thirty-seven eyes of 37 patients who had an implantation of autologous auricular cartilage-reinforced (AACR) Boston Type-II Kpro (BK2) were included in the current study.
Chin Med J (Engl)
February 2023
Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China.
Contrast Media Mol Imaging
October 2022
Department of Cardiology, Haikou Hospital, Xiangya Medical College, Central South University, Changsha 410000, Hunan, China.
Cardiovascular medicine patients have complex conditions and rapid progress. They will cause a variety of complications during the illness and are difficult to care for. In addition, the above departments have many treatment tools, complex nursing points, and nursing risks.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
June 2021
Department of Dermatology and Venereology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Background: Verrucous epidermal naevi (VEN) are benign skin tumours, considered keratinocytic epidermal naevi, that appear at birth or early childhood. VEN may display a range of appearances, depending on patient age. Although the number of studies regarding VEN is increasing, the exact mechanism of VEN is still unknown.
View Article and Find Full Text PDF